Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Reteplase> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- Reteplase abstract "Reteplase (trade names Retavase, Rapilysin) is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them. Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein. It is produced in the bacterium Escherichia coli.[citation needed]Reteplase is similar to recombinant human tissue plasminogen activator (alteplase), but the modifications give reteplase a longer half-life of 13–16 minutes. Reteplase also binds fibrin with lower affinity than alteplase, improving its ability to penetrate into clots.Reteplase was approved by the Food and Drug Administration in 1996.As reteplase is able to penetrate inside the thrombi, an enhanced fibrinolytic activity will be achieved → rapid reperfusion → low incidence of bleeding.".
- Reteplase atcPrefix "B01".
- Reteplase atcSuffix "AD07".
- Reteplase casNumber "133652-38-7".
- Reteplase drugbank "DB00015".
- Reteplase fdaUniiCode "DQA630RIE9".
- Reteplase wikiPageID "4958583".
- Reteplase wikiPageRevisionID "587967727".
- Reteplase atcPrefix "B01".
- Reteplase atcSuffix "AD07".
- Reteplase auto "yes".
- Reteplase c "1736".
- Reteplase casNumber "133652".
- Reteplase chemspiderid "NA".
- Reteplase date "December 2009".
- Reteplase drugbank "DB00015".
- Reteplase h "2671".
- Reteplase hasPhotoCollection Reteplase.
- Reteplase kegg "D05721".
- Reteplase molecularWeight "39589.6".
- Reteplase n "499".
- Reteplase o "522".
- Reteplase s "22".
- Reteplase tradename "Retavase".
- Reteplase unii "DQA630RIE9".
- Reteplase verifiedrevid "464381256".
- Reteplase subject Category:Antithrombotic_enzymes.
- Reteplase type Abstraction100002137.
- Reteplase type Activator114723079.
- Reteplase type AntithromboticEnzymes.
- Reteplase type Catalyst114723628.
- Reteplase type Chemical114806838.
- Reteplase type Compound114818238.
- Reteplase type Enzyme114732946.
- Reteplase type Macromolecule114944888.
- Reteplase type Material114580897.
- Reteplase type Matter100020827.
- Reteplase type Molecule114682133.
- Reteplase type OrganicCompound114727670.
- Reteplase type Part113809207.
- Reteplase type PhysicalEntity100001930.
- Reteplase type Protein114728724.
- Reteplase type Relation100031921.
- Reteplase type Substance100019613.
- Reteplase type Thing100002452.
- Reteplase type Unit109465459.
- Reteplase type Drug.
- Reteplase type DrugProduct.
- Reteplase type FunctionalSubstance.
- Reteplase comment "Reteplase (trade names Retavase, Rapilysin) is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them. Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator, which has been modified to contain 357 of the 527 amino acids of the original protein.".
- Reteplase label "Reteplase".
- Reteplase label "Reteplase".
- Reteplase label "Reteplase".
- Reteplase sameAs Reteplase.
- Reteplase sameAs レテプラーゼ.
- Reteplase sameAs Reteplase.
- Reteplase sameAs m.0cx3ng.
- Reteplase sameAs Q3933703.
- Reteplase sameAs Q3933703.
- Reteplase sameAs DB00015.
- Reteplase sameAs Reteplase.
- Reteplase wasDerivedFrom Reteplase?oldid=587967727.
- Reteplase isPrimaryTopicOf Reteplase.